GH and GnRH analog treatment in children who enter puberty at short stature

Journal of Pediatric Endocrinology and Metabolism

Volumn 10, Issue 6, 1997, Pages 623-628

  Tanaka, Toshiaki ^a,b   Satoh, Mari ^c   Yasunaga, Toru ^a   Horikawa, Reiko ^c   Tanae, Ayako ^b   Hibi, Itsuro ^b  

^a NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^b NATIONAL CHILDREN S HOSPITAL   (Japan)

^c TOHO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BUSERELIN ACETATE; GONADORELIN DERIVATIVE; GROWTH HORMONE; HUMAN GROWTH HORMONE; LEUPRORELIN; TRIPTORELIN;

ADOLESCENT; ARTICLE; BODY HEIGHT; BONE AGE; BONE MATURATION; CLINICAL ARTICLE; DRUG EFFICACY; DRUG MIXTURE; FEMALE; GENDER; GROWTH HORMONE DEFICIENCY; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; INTRANASAL DRUG ADMINISTRATION; MALE; PUBERTY; SCHOOL CHILD; SHORT STATURE; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0031472273     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.1997.10.6.623     Document Type: Article

References (11)

1. Takano K, Tanaka T, Saito T. Psychosocial adjustment in a large cohort of adults with growth hormone deficiency treated with growth hormone in childhood: summary of a questionnaire survey. Acta Paediatr 1994; Suppl 399: 16-19.
2. Tanaka T. Pubertal development in growth hormone-treated children. Clin Pediatr Endocrinol 1994; 3 (Suppl 5): 79-86.
3. Tanaka T, Yoshizawa A, Tanae A, Hibi I, Shizume K. Relationships between puberty and growth at adolescence in growth-hormone-deficient males: effect of growth hormone and of associated gonadal suppression therapy. Horm Res 1990; 33 (Suppl 4): 102-105.
4. Hashimoto N, Tanaka T, Tanae A, Yokoya S, Hibi I. Growth pattern and final height of non-endocrine short stature. J Jpn Pediatr Soc 1992; 96: 147-151.
5. Tanaka T, Komatsu K, Takada G, Miyashita M, Ohno T. Prediction of adult height in healthy Japanese children. Acta Paediatr 1996; Suppl 417: 57-60.
6. Hibi I, Tanaka T, Tanae A, Kagawa J, Hashimoto N, Yoshizawa A, Shizume K. The influence of gonadal function and the effect of gonadal suppression treatment on final height in growth hormone (GH)-treated GH-deficient children. J Clin Endocrinol Metab 1989; 69: 221-226.
7. Murata M. Japanese specific bone age standard on the TW2. Clin Pediatr Endocrinol 1993; 2 (Suppl 3): 35-41.
8. Smith E, Boyd J, Frank GR, et al. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med 1994; 331: 1056-1061.
9. Morishima A, Grumbach MM, Simpson ER, Fisher C, Qin K. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J Clin Endocrinol Metab 1995; 80: 3689-3696.
10. Satoh M, Tanaka T, Hibi I. Analysis of bone age maturation and growth velocity in isolated growth hormone (GH) deficient boys with and without gonadal suppression therapy and in GH deficient boys with associated gonadotropin deficiency. J Pediatr Endocr Metab 1997; 10: (this issue).
11. Balducci R, Toscano V, Mangiantini A, Municchi G, Vaccaro F, Picone S, et al. Adult height in short normal adolescent girls treated with gonadotropin-releasing hormone analog and growth hormone. J Clin Endocrinol Metab 1995; 80: 3596-3600.